2/5
06:08 pm
vktx
The Commoditization Of GLP-1s: Why Viking's Maintenance Hedge Is Falling Short [Seeking Alpha]
Medium
Report
The Commoditization Of GLP-1s: Why Viking's Maintenance Hedge Is Falling Short [Seeking Alpha]
2/4
04:05 pm
vktx
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026
High
Report
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026
1/27
01:39 pm
vktx
2 Biotech Stocks Set to Rebound in 2026 [Yahoo! Finance]
Low
Report
2 Biotech Stocks Set to Rebound in 2026 [Yahoo! Finance]
1/27
12:27 pm
vktx
Why Viking Therapeutics (VKTX) Is Down 6.5% After Publishing VK2735 Phase 2 Obesity Trial Results And What's Next [Yahoo! Finance]
Low
Report
Why Viking Therapeutics (VKTX) Is Down 6.5% After Publishing VK2735 Phase 2 Obesity Trial Results And What's Next [Yahoo! Finance]
1/26
03:29 am
vktx
Viking Therapeutics, Inc. (VKTX) Advances Obesity Drug Development and Expands Metabolic Disease Pipeline [Yahoo! Finance]
Medium
Report
Viking Therapeutics, Inc. (VKTX) Advances Obesity Drug Development and Expands Metabolic Disease Pipeline [Yahoo! Finance]
1/24
01:43 pm
vktx
The Best Stocks to Invest $40 in to Start the New Year Off Right [Yahoo! Finance]
Medium
Report
The Best Stocks to Invest $40 in to Start the New Year Off Right [Yahoo! Finance]
1/23
07:09 pm
vktx
Assessing Viking Therapeutics (VKTX) Valuation As Shares Rebound Over The Past Week [Yahoo! Finance]
Low
Report
Assessing Viking Therapeutics (VKTX) Valuation As Shares Rebound Over The Past Week [Yahoo! Finance]
1/23
05:09 am
vktx
Viking Therapeutics (NASDAQ:VKTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Viking Therapeutics (NASDAQ:VKTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/22
07:49 am
vktx
Viking Therapeutics (NASDAQ:VKTX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Viking Therapeutics (NASDAQ:VKTX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/21
03:53 pm
vktx
2 Bargain Stocks You Can Buy for Less Than $100 Right Now [Yahoo! Finance]
Low
Report
2 Bargain Stocks You Can Buy for Less Than $100 Right Now [Yahoo! Finance]
1/21
11:00 am
vktx
1 Stock That Could Soar by 175%, According to Wall Street [Yahoo! Finance]
Low
Report
1 Stock That Could Soar by 175%, According to Wall Street [Yahoo! Finance]
1/20
03:41 pm
vktx
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? [Yahoo! Finance]
Low
Report
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? [Yahoo! Finance]
1/16
08:36 pm
vktx
Is Viking Therapeutics (VKTX) Now Attractive After A Strong DCF Upside Signal [Yahoo! Finance]
Low
Report
Is Viking Therapeutics (VKTX) Now Attractive After A Strong DCF Upside Signal [Yahoo! Finance]
1/15
05:21 am
vktx
Viking Therapeutics (VKTX) Soars 11.9% on Strong Weight Loss Market Outlook [Yahoo! Finance]
Medium
Report
Viking Therapeutics (VKTX) Soars 11.9% on Strong Weight Loss Market Outlook [Yahoo! Finance]
1/13
09:18 am
vktx
Jim Cramer Says “I'm a Eli Lilly Guy” When Asked About Viking Therapeutics [Yahoo! Finance]
Medium
Report
Jim Cramer Says “I'm a Eli Lilly Guy” When Asked About Viking Therapeutics [Yahoo! Finance]
1/12
07:00 am
vktx
Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
Low
Report
Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
1/11
06:40 am
vktx
What Investors Should Know About a Viking Therapeutics Insider's $2 Million Stock Sale [Yahoo! Finance]
Low
Report
What Investors Should Know About a Viking Therapeutics Insider's $2 Million Stock Sale [Yahoo! Finance]
1/10
07:02 pm
vktx
Is Viking Therapeutics (VKTX) Quietly Recasting Its Metabolic Ambitions With VK2735 And New Leadership? [Yahoo! Finance]
Low
Report
Is Viking Therapeutics (VKTX) Quietly Recasting Its Metabolic Ambitions With VK2735 And New Leadership? [Yahoo! Finance]
1/9
07:03 pm
vktx
VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug [Yahoo! Finance]
Low
Report
VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug [Yahoo! Finance]
1/8
07:59 pm
vktx
Lightning Round: QXO is a buy, says Jim Cramer [CNBC]
Low
Report
Lightning Round: QXO is a buy, says Jim Cramer [CNBC]
1/8
07:27 am
vktx
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity [Yahoo! Finance]
Low
Report
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity [Yahoo! Finance]
1/8
07:00 am
vktx
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity
Low
Report
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity
1/7
07:13 am
vktx
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer [Yahoo! Finance]
Low
Report
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer [Yahoo! Finance]
1/7
07:00 am
vktx
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
Low
Report
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
1/5
07:21 pm
vktx
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]
Low
Report
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]